Randomized Trial of Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy: Crossover Analysis
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 61 (6) , 1247-1253
Abstract
No abstract availableKeywords
Funding Information
- Gateway for Cancer Research
This publication has 11 references indexed in Scilit:
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline UpdateJournal of Clinical Oncology, 2020
- Prevalence of Chronic Pain and High-Impact Chronic Pain in Cancer Survivors in the United StatesJAMA Oncology, 2019
- Inside the Scrambler Therapy, a Noninvasive Treatment of Chronic Neuropathic and Cancer Pain: From the Gate Control Theory to the Active Principle of InformationIntegrative Cancer Therapies, 2019
- Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral NeuropathyJournal of Clinical Oncology, 2017
- Anticipating the “Silver Tsunami”: Prevalence Trajectories and Co-Morbidity Burden among Older Cancer Survivors in the United StatesCancer Epidemiology, Biomarkers & Prevention, 2016
- The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of FallingJAMA Neurology, 2016
- Pilot Trial of a Patient-Specific Cutaneous Electrostimulation Device (MC5-A Calmare®) for Chemotherapy-Induced Peripheral NeuropathyJournal of Pain and Symptom Management, 2010
- Patient Perceptions Associated With Chemotherapy-Induced Peripheral NeuropathyClinical Journal of Oncology Nursing, 2010
- Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-l-carnitinePain, 2008
- Transcutaneous Electrical Nerve Stimulation: Mechanisms, Clinical Application and EvidenceReviews in Pain, 2007